Atrial tachycardia

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Atrial tachycardia | |
|---|---|
| |
| Synonyms | Atrial ectopic tachycardia, AET |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Palpitations, dizziness, shortness of breath, chest pain |
| Complications | Heart failure, stroke |
| Onset | Any age, more common in adults |
| Duration | Can be paroxysmal or chronic |
| Types | N/A |
| Causes | Abnormal electrical activity in the atria |
| Risks | Hypertension, coronary artery disease, valvular heart disease |
| Diagnosis | Electrocardiogram (ECG), Holter monitor, event monitor |
| Differential diagnosis | Atrial fibrillation, atrial flutter, supraventricular tachycardia |
| Prevention | N/A |
| Treatment | Medications, catheter ablation, cardioversion |
| Medication | Beta blockers, calcium channel blockers, antiarrhythmic drugs |
| Prognosis | N/A |
| Frequency | Relatively uncommon compared to other arrhythmias |
| Deaths | Rarely directly fatal, but can lead to complications |
Atrial tachycardia is a type of supraventricular tachycardia that originates in the atria of the heart. It is characterized by a rapid heart rate that exceeds the normal resting rate, typically over 100 beats per minute. This condition can occur in individuals with or without structural heart disease and can be paroxysmal or sustained.
Pathophysiology[edit]
Atrial tachycardia results from abnormal electrical activity in the atria. This can be due to enhanced automaticity, triggered activity, or reentrant circuits. In enhanced automaticity, certain atrial cells spontaneously depolarize at a faster rate than the sinoatrial node, leading to a rapid heart rate. Triggered activity involves afterdepolarizations that reach threshold and cause premature atrial contractions. Reentrant circuits occur when there is a loop of electrical activity within the atria, causing repeated activation of the atrial tissue.
Clinical Presentation[edit]
Patients with atrial tachycardia may experience symptoms such as palpitations, dizziness, shortness of breath, and chest pain. In some cases, atrial tachycardia can lead to heart failure or syncope if the heart rate is excessively high or if the patient has underlying heart disease.
Diagnosis[edit]
The diagnosis of atrial tachycardia is typically made using an electrocardiogram (ECG). The ECG will show a rapid atrial rate with abnormal P wave morphology, which differs from the normal sinus rhythm. Additional diagnostic tools may include Holter monitoring, event monitors, and electrophysiological studies to determine the mechanism and origin of the tachycardia.
Treatment[edit]
Treatment of atrial tachycardia depends on the underlying cause and the severity of symptoms. Options include:
- Medications: Antiarrhythmic drugs such as beta-blockers, calcium channel blockers, and class I or III antiarrhythmics can be used to control the heart rate or restore normal rhythm.
- Catheter Ablation: This procedure involves the use of radiofrequency energy to destroy the abnormal tissue causing the tachycardia.
- Lifestyle Modifications: Avoiding triggers such as caffeine, alcohol, and stress can help reduce episodes of atrial tachycardia.
Prognosis[edit]
The prognosis for patients with atrial tachycardia varies depending on the presence of underlying heart disease and the effectiveness of treatment. Many patients can achieve good control of their symptoms with appropriate therapy.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
